Pankaj Patel, CMD, Cadila Healthcare (Photo: Yasin D) Ahmedabad-based pharma major Cadila Healthcare which covered a long journey from being a Rs 250-crore company in 1995 to the Rs 9,800-crore behemoth that it is today. The company feels that the ... Smart Investor, 1 day ago
We're looking for buyouts in the US: Pankaj R Patel - Smart Investor, 20 hours ago
1 images for "cadila pharmaceutical"
The pharma firm already has 200 brands, with three or four being in the top five in India, says Rajiv Modi, Chairman CEO, Cadila Pharmaceuticals.Money Control, 3 weeks ago Can Indian pharmafight back? Hindu Business Line, 1 week ago Good news: Drugs in India just got cheaper. List inside Times of India, 1 week ago PHARMA COMPANIES FACE PRICE PRESSURE IN US MARKET IPA Newspack.com, 2 weeks ago
The pharmaceutical company Zydus Cadila has secured the final approval from the US Food and Drug Administration (USFDA) to sell its anti-diabetic Glyburide tablets in the US market. The drug will be marketed in strengths of 1.25, 2.5 and 5 mg. It ...Pharmacy Choice, 1 week ago Crisil rings warning bell for pharma on US slowdown Economic Times, 1 week ago Prashant Sharma of Zydus Cadila promoted to a new role People Matters, 3 weeks ago FDA nod for Zydus arm’s drug Business Line, 1 month ago
Global pharmaceutical company Cadila Healthcare on Friday posted a 11 percent increase in its net profit at Rs 388.7 crore for the fourth quarter ended March as compared to Rs.350.4 crore in the year-ago period, on account of robust sales. Total ...4 Traders, 1 week ago Cadila Healthcare Q4 net rises 11 percent Prokerala, 1 week ago Cadila Healthcare Ltd 13 May 2016 India Infoline, 1 week ago
More from: , Yahoo! India...and 1 other sources
Awareness was raised on tuberculosis where more than 300 villagers underwent health checkups and were given consultations Cadila Pharmaceuticals in association with Gujarat State Tuberculosis Association and Sparsh Hospital recently organised a ...Financial Express, 1 month ago
Shortly after receiving an FDA warning letter for major quality deficiencies, Indian drugmaker Cadila Pharmaceuticals was slammed for data integrity issues and GMP violations by the World Health Organization. The inspection — involving the ...FDA News, 1 month ago Cadila Pharma initiates awareness campaigns to observe World TBDay CPhI.cn, 1 month ago Cadila Pharmaceuticals initiates awareness campaigns across Gujarat to observe World TB Day PharmaBiz, 2 months ago Cadila Pharmaceuticals Ltd initiates awareness campaigns to observe World TB (Tuberculosis) Day - Pocket News Alert.com, 2 months ago
Swedish pharmaceutical company Moberg Pharma AB (OMX: MOB) announced on Tuesday that it has entered into a development and license agreement with Cadila Pharmaceuticals Limited, a large healthcare manufacturing group in India, for BUPI, a novel ...Bloomberg, 2 months ago Moberg Pharma AB Interim Report January - March 2016 Yahoo! Finance UK and Ireland, 2 weeks ago MOBERG PHARMA AB : Interim report January - March 2016 4 Traders, 2 weeks ago Moberg Pharma partners with Cadila Pharmaceuticals for late-stage development and commercialisation of BUPI for oral mucositis Bloomberg, 2 months ago
The BSE Healthcare index opened lower at 15,531.27 points as against its previous close of 15,540.06 points. It hit a high and a low of 15,593.73 and 15,444.71 points respectively before closing at 15,563.49 points, up by 0.15%. Pharma stocks ...India Infoline, 1 week ago
SENSEX 25463.09 327.13 1.27% NIFTY 7803.65 96.75 1.22% Industry: Medical/Healthcare Company Cadila Healthcare Ltd Cadila Healthcare is currently trading at Rs. 335.20, up by 1.75 points or 0.52% from its previous closing of ...Finalaya.com, 1 week ago Cadila Healthcare plans to raise Rs 18,500 crore Press Trust of India, 3 weeks ago Cadila Healthcare plans to raise funds through securities The Hindu, 3 weeks ago Cadila to Seek Investors' Nod to Raise up to Rs 10,000 Cr NDTV Profit, 1 month ago
More from: , Finalaya.com...and 1 other sources
New Delhi, May 11 () US-based pharmaceuticals firm Gilead Sciences Inc today said prices of its hepatitis C drug Sovaldi will not be impacted by granting of patent to it by the country's patent office. Although the medicine is quoted at USD 1,000 ...Times of India, 1 week ago Patent not to impact hepatitis C drug price in India: Gilead Times of India, 1 week ago Gilead's License on Hepatitis C drugs, Sofosbuvir and Ledipasvir: a Fool's Bargain hep Coalition, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!